As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >

CNRGH – National Center of Human Genomics Research

Genopole Campus 2
Bulding G2 – 2 rue Gaston Crémieux – CP 5721
91057 EVRY cedex – FRANCE
Phone : +33 1 60 87 83 44 – Email :

Manager : DELEUZE Jean-François
Web Site >
CNRGH / CEA / François Jacob Institut CNRGH / CEA / François Jacob Institut


#Genomics / Postgenomics # #Synthetic biology #Systems Biology

  • Genotyping
  • Sequencing
  • Epigenetics
  • Bioinformatics
  • Bioanalysis
  • Mathematics and biostatistics
  • Functional genomics
  • Human disease
  • Translational medicine
  • Personalized medicine

Field of Activity

Human genetics, epigenetics, genomics and post-genomics.
– Research in and the characterization of genes and biomarkers associated with human disease.
– Analysis of human genome variations in individuals and populations.
– 3D structural analysis of the human genome.
– Strategies for functional genomics.
– Technology surveillance and development.
– Deployment of tools and strategies for personalized medicine.

The CNRGH is a national-level center whose mission is to provide high throughput genotyping and sequencing services with the objective of optimizing genetic and genomic research for human diseases.

It is a division of the CEA, within the newly-created François Jacob Institute of Biology. The CNRGH offers its expertise and capacities in data production, stocking and analysis to the scientific community for projects in medical genomics: autoimmune, cardiovascular and infectious diseases, psychiatric disorders, cancers (breast, prostate, kidney), and more. The center evaluates and integrates the most advanced technologies in genomics to maintain its world-scale competitiveness.

To achieve its missions and objectives, the CNRGH has deployed a number of integrated structures: a biobank for the management and preparation of a wide range of biological samples; a high-throughput sequencing facility for pangenomic studies; a medium-throughput facility for smaller studies; a technological development group to evaluate emerging technologies and ensure their transfer; epigenetics, functional genomics and bioinformatics laboratories; a biostatistics group; and finally a group for data quality control.

The CNRGH participates in national and European programs for both the development of technologies and the study of human diseases. It is also involved in many ambitious projects such as the decoding of the genetic causes of rare diseases, the study of the genetic bases of autism and Alzheimer’s disease, or the exploration of the genetic foundation of toxicity for certain breast cancer treatments.

The CNRGH also carries out its own research in functional genomics, focused particularly on the influence of the 3D structure of DNA and the development of an integrated approach to the human ecosystem via the study of microbiome/human genome interactions. The center also explores other innovative technologies, such as the search for blood-borne DNA fragments traceable to specific organs, which could serve as universal biomarkers.

Finally, the CNRGH has also committed to the production of genetic history data on the French population to provide the scientific community with a point of reference for projects in personalized medicine. Every year, the CNRGH teams undertake about 100 research projects and participate in the publication of the results in renowned international scientific journals.


    The CNRGH plays multiple roles within the French Investissements d’Avenir program:

    – It is a founding partner of the laboratory of excellence GENMED and the national infrastructure France Génomique.

    – It furthermore contributes to the ANR’s project INCEPTION (disease emergence) and learning hospital projects such as FIGHT-HF (heart failure) and CHOPIN (cholesterol).

    – The CNRGH is also a major participant in the Genomic Medicine France 2025 plan, where, in partnership with Genopole, it is conducting the set-up and management of CRefIX, the future reference center for innovation, expertise and transfer.

  • Teams

    – Sequencing, Genotyping directed by Marie-Thérèse BIHOREAU

    – Bank directed by Anne BOLAND-AUGE

    – Epigenetics and Environment directed by Jörg TOST

    – Human genomics and production platform directed by Robert OLASO

    – Bioanalysis directed by Eric BONNET

    – Math and Statistics directed by Edith LE FLOCH

    – Bioinformatics directed by Vincent MEYER

    – Functional genomic development directed by Jean-François DELEUZE

Genopole’s Laboratories

#Genomics / Postgenomics

In same field

LBEPS - Laboratoire genopolitain


LBEPS is a laboratory dedicated to the physiology and biology of exercise implementing a translation strategy from the physiology of humans in motion to the study of cellular, molecular, genetic and epigenetic responses to exercise and recovery

Inserm - Logo


ART-TG is a pre-GMP stage R&D laboratory aiming to bridge a gap between research and clinical or industrial applications. It has pharmaceutical expertise for product development and product manufacturing, specifically for genomic therapy approaches.

I-Stem - laboratoire génopolitain


The institute evaluates the therapeutic potential of all types of stem cells in the setting of monogenic diseases.

Genethon Laboratory


Gene therapy for rare genetic diseases. Research, preclinical and clinical development of gene therapies for neuromuscular and other rare genetic diseases.



Research at LGRK focuses on the homeostasis, regenerative potential and radiosensitivity of human epidermal stem cells.

Integrare - Genopole's Laboratory


The Integrare research unit aims to develop effective and safe gene therapies for rare genetic diseases such as neuromuscular disorders, metabolic diseases or blood/immune disorders

Genoscope - CNS - Genopole's laboratory

Genoscope – CNS

Genomics and postgenomics of biodiversity – Metagenomics of microorganisms from the environment.

Genoscope - CNS - Genopole's laboratory

Genomics Metabolics

The Metabolic Genomics UMR is the fundamental research structure of Genoscope – National Sequencing Center – Study of the chemistry and the diversity of organisms. Genomics of eukaryotes, prokaryotes and metagenomes.

GenHotel European Research Laboratory For Rheumatoid Arthritis - Genopole's laboratory


Genomics – Genetic Statistics Research on genetic susceptibility to complex diseases through genomic analyses with a focus on rheumatoid arthritis.



Plant genomics. Detection, analysis and management of plant species polymorphism.

View all >
With the support from
Région île de France